| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 13,648,000 | 16,629,000 | 15,061,000 | 15,837,000 | | Cost of Revenue | 2,814,000 | 3,907,000 | 2,848,000 | 2,866,000 | | | Gross Profit | 10,834,000 | 12,722,000 | 12,213,000 | 12,971,000 | | | Operating Expenses | | Research Development | 2,212,000 | 2,290,000 | 2,283,000 | 2,407,000 | | Selling General and Administrative | 3,894,000 | 4,493,000 | 3,931,000 | 4,880,000 | | Non Recurring | 290,000 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,438,000 | 5,939,000 | 5,999,000 | 5,684,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (388,000) | (301,000) | (8,000) | 284,000 | | Earnings Before Interest And Taxes | 4,050,000 | 5,638,000 | 5,991,000 | 5,968,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 4,050,000 | 5,638,000 | 5,991,000 | 5,968,000 | | Income Tax Expense | 1,073,000 | 1,464,000 | 1,618,000 | 1,671,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,977,000 | 4,174,000 | 4,373,000 | 4,297,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,977,000 | 4,174,000 | 4,373,000 | 4,297,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,977,000 | $4,174,000 | $4,373,000 | $4,297,000 |
|
3.07% Nasdaq 
Income Statement
